P/E ratio for Ampio Pharmaceuticals (AMPE)
P/E ratio as of April 2025 (TTM): -0.0013
According to Ampio Pharmaceuticals's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.00132147. At the end of 2022 the company had a P/E ratio of -0.2378.
P/E ratio history for Ampio Pharmaceuticals from 2008 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.2378 | -97.51% |
| 2021 | -9.57 | -57.27% |
| 2020 | -22.4 | 270.06% |
| 2019 | -6.05 | -689.36% |
| 2018 | 1.03 | -104.1% |
| 2017 | -25.0 | 743.03% |
| 2016 | -2.97 | -53.71% |
| 2015 | -6.42 | 39.89% |
| 2014 | -4.59 | -63.36% |
| 2013 | -12.5 | 8.37% |
| 2012 | -11.6 | 135.75% |
| 2011 | -4.90 | -14.93% |
| 2010 | -5.76 | -30.97% |
| 2009 | -8.35 | -78.83% |
| 2008 | -39.4 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | -20.3 | 1,538,587.98% | 🇺🇸 USA |
 | 11.0 | -834,768.97% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |
 | -82.8 | 6,263,583.63% | 🇺🇸 USA |
 | 44.4 | -3,359,086.58% | 🇺🇸 USA |
 | 16.7 | -1,267,264.60% | 🇺🇸 USA |
 | 13.3 | -1,005,011.20% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.